Dr. Samir Kulkarni is currently working as Senior Principal Scientist in Pharmaceutical Sciences, Pfizer Chemical R＆D working in Groton, CT. He earned his Ph.D. in Chemical Engineering at Delft...
By Dr. Ashish Punia, Ph.D. Merck & Co., Rahway, NJ A considerable portion of small molecule pharmaceutical drugs suffer from poor aqueous solubility. Amorphous solid dispersion (ASD) is a...
Ashish Punia is a Principal Scientist in the Materials and Biophysical Characterization Group at Merck & Co., Inc., Rahway NJ. Prior to joining Merck, he received his PhD in...
By Prof. Rajesh N. Davé, Distinguished Professor, Chemical & Materials Engineering, New Jersey Institute of Technology, Newark, NJ 07102 Distinguished Professor of Chemical, Biological and Pharmaceutical Engineering, Center for...
Prof. Rajesh Davé Fellow of the American Institute of Chemical Engineers (AIChE), American Association of Pharmaceutical Scientists (AAPS), and National Academy of Inventors (NAI) is a Distinguished Professor of...
Aaron Moment researches methodologies for developing manufacturing processes for fine chemical, pharmaceutical and biopharmaceutical products. By applying advances in sensing, imaging, visualization, modeling, simulation, and materials, Aaron devises more...
VP, head of CMC, Supply Chain and QA Chong-Hui Gu, Ph. D, is responsible for CMC, supply chain and QA at Foghorn Therapeutics. He has over 20 years of...
By Prof. Changquan Calvin Sun, Ph.D. Professor, University of Minnesota The development of a quality tablet product requires overcoming deficiencies in pharmaceutical properties of tablets to meet several performance...
By Prof. Ronald Siegel, Professor and Department Head, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455 For many low solubility drugs, the crystalline form is unfavorable due to...
Professor Siegel received his ScD degree in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology (MIT) in 1984. From 1984 to 1998 he was on the...
